Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$13.69 USD
-0.31 (-2.21%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $13.69 0.00 (0.00%) 6:08 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RCUS 13.69 -0.31(-2.21%)
Will RCUS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RCUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RCUS
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Other News for RCUS
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
Here is the next potential market catalyst
Arcus Biosciences Inc (RCUS) Q2 2024 Earnings: Revenue Surpasses Estimates at $39M, GAAP EPS at ...
Arcus Biosciences reports Q2 EPS ($1.02), consensus ($1.10)
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors